Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Thoracic 3Other hematologic neoplasm 2Breast 2Lymphoid 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Lung Neoplasms 3Radiation Pneumonitis 1Postoperative Complications 1Breast Neoplasms 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Respiratory Function Tests × Thoracic × Clear all
NCT06925295 2026-01-02

(XeRTLC)

University of Iowa

Phase 2 Recruiting
15 enrolled
Thoracic

Lung Neoplasms

NCT02735746 2025-08-22

HFFLI

Cedars-Sinai Medical Center

Completed
60 enrolled
BreastThoracic

Breast Neoplasms, Lung Neoplasms, Radiation Pneumonitis

NCT06338007 2024-04-17

Relationship Between Hand Dynamometer Measurements, PFT, and mFI With Postoperative Outcomes

Atatürk Chest Diseases and Chest Surgery Training and Research Hospital

Unknown
100 enrolled
Thoracic

Lung Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡